NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...
The decline in stock value comes as analysts express mixed views on the company's quarterly performance. While ResMed achieved a 10% revenue increase compared to the same quarter last year, some ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
Joey Luther was arrested last week and charged with wire fraud, smuggling and distributing counterfeit drugs for allegedly selling fake Botox.
The birth control drug name-dropped in Project 2025 is suddenly getting new attention, thanks to research suggesting it could ...
AI Optics, a biotech startup backed by NYU Langone and raising in stealth, announced clearance this week from the Food and ...
WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
One aimed to expand the definition of crops, livestock, and livestock products to include cannabis and the second would ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback